Bulk Inquiry
Amisulpride
- DAN 2163
Axon 1381
CAS:
71675-85-9
Purity:
99%
- Soluble in 0.1N HCl(aq)
- MF: C17H27N3O4S
- MW: 369.48
Description
Amisulpride is a high-affinity dopamine D2 and D3 receptor antagonist with reported Ki values of 2.8 nM at D2 and 3.2 nM at D3.
Amisulpride is an atypical antipsychotic reference compound used to study D2-family receptor blockade in mesolimbic and striatal pathways. Its pharmacology is relevant to psychosis, prolactin regulation and dopamine-dependent behavioral responses.
Key Features
- High-affinity D2/D3 receptor antagonist
- Ki: 2.8 nM (D2) and 3.2 nM (D3)
- Clinically established atypical antipsychotic pharmacology
- Useful for mesolimbic versus striatal dopamine studies
Applications
- D2 and D3 receptor binding assays
- Antipsychotic mechanism research
- Dopamine-dependent behavioral models
- Prolactin and neuroendocrine signaling studies
More Information
| Parent CAS No. | 71675-85-9 |
|---|---|
| Chemical Name | 4-Amino-5-ethanesulfonyl-N-(1-ethyl-pyrrolidin-2-ylmethyl)-2-methoxy-benzamide |
| SMILES | C1(C(=O)NCC2CCCN2CC)C=C(C(N)=CC=1OC)S(=O)(=O)CC |
| MFCD | MFCD00866691 |
| InChi | InChI=1S/C17H27N3O4S/c1-4-20-8-6-7-12(20)11-19-17(21)13-9-16(25(22,23)5-2)14(18)10-15(13)24-3/h9-10,12H,4-8,11,18H2,1-3H3,(H,19,21) |
| InChiKey | NTJOBXMMWNYJFB-UHFFFAOYSA-N |
| CID | 2159 |
| Short Description | D2/3 antagonist |
Amisulpride
high-affinity D2/D3 receptor antagonist
DAN 2163
DAN2163
DAN-2163
DRD3
DRD2
D2/D3 receptor
D2
D3
Antagonist
dopamine signaling
D2 and D3 receptor binding assays
Antipsychotic mechanism research
Dopamine-dependent behavioral models
Prolactin and neuroendocrine signaling studies
behavioral neuroscience
GPCR pharmacology
signal transduction
receptor pharmacology
neuroscience
CAS 71675-85-9
Axon Medchem
Axon 1381
Supplier
Vendor
References
- H Loo et al. Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia. Br. J. Psychiatry 1999, 170, 18-22.
- H Choemaker et al. Neurochemical characteristics of amisulpride, an atypical dopamine D2/D3 receptor antagonist with both presynaptic and limbic selectivity. J. Pharmacol. Exp. Ther. 1997, 280(1), 83-97.
Related Products
Other Categories
Get a Quote for
Loading...


